Suppr超能文献

健康的HLA - A2阳性个体中针对人巨细胞病毒pp65的T细胞反应分析。

Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals.

作者信息

Schalich Juliane, Vytvytska Oresta, Zauner Wolfgang, Fischer Michael B, Buschle Michael, Aichinger Gerald, Klade Christoph S

机构信息

InterCell AG, Campus Vienna Biocenter 6, A-1030 Vienna, Austria.

出版信息

Biol Chem. 2008 May;389(5):551-9. doi: 10.1515/bc.2008.065.

Abstract

Human cytomegalovirus (HCMV) is contained by T-lymphocyte responses focused towards the major tegument protein pp65. To systematically identify T-cell epitopes, we applied the following strategy: 441 overlapping 15mer peptides spanning the entire HCMV pp65 antigen in 1-aa steps were screened in enzyme-linked immunospot (ELispot) assays for interferon gamma (IFN-gamma) secretion by peripheral blood mononuclear cells (PBMCs) from nine healthy HCMV-seropositive subjects expressing human leukocyte antigen (HLA)-A2. This analysis confirmed a number of previously known epitopes and revealed several new ones. A total of 26 epitopes were identified, including 14 HLA-A2, four HLA-B7, -B35, -812 and -B44 restricted class I epitopes, six class II epitopes, and two epitopes of unknown restriction. Three novel HLA-A2 epitopes were confirmed using T2-cells, and one peptide for which only binding data had been published so far was verified. Two novel class II epitopes were confirmed by intracellular cytokine staining. Responses were usually oligoclonal against up to seven HLA-A2 epitopes, albeit with a few dominating epitopes. Clusters of overlapping epitopes (hot-spots) were identified. These and the newly identified T-cell epitopes may be of great value for epitope-based immunotherapeutic approaches, including peptide vaccines.

摘要

人类巨细胞病毒(HCMV)受到针对主要被膜蛋白pp65的T淋巴细胞反应的控制。为了系统地鉴定T细胞表位,我们采用了以下策略:以1个氨基酸的步长筛选覆盖整个HCMV pp65抗原的441个重叠15聚体肽,通过酶联免疫斑点(ELispot)分析检测来自9名表达人类白细胞抗原(HLA)-A2的健康HCMV血清阳性受试者的外周血单个核细胞(PBMC)分泌的干扰素γ(IFN-γ)。该分析证实了一些先前已知的表位,并发现了几个新的表位。总共鉴定出26个表位,包括14个HLA-A2、4个HLA-B7、-B35、-B12和-B44限制性I类表位、6个II类表位以及2个限制性未知的表位。使用T-2细胞证实了3个新的HLA-A2表位,并验证了一个迄今为止仅公布了结合数据的肽段。通过细胞内细胞因子染色证实了2个新发现的II类表位。反应通常是针对多达7个HLA-A2表位的寡克隆反应,尽管有一些主要表位。鉴定出了重叠表位簇(热点)。这些以及新发现的T细胞表位对于基于表位的免疫治疗方法,包括肽疫苗,可能具有重要价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验